Q14517 (FAT1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 133.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protocadherin Fat 1 Alternative name(s): Cadherin family member 7 Cadherin-related tumor suppressor homolog Protein fat homolog Cleaved into the following chain: | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 4588 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays an essential role for cellular polarization, directed cell migration and modulating cell-cell contact By similarity. |
| Subunit structure | Interacts (via the C-terminus 4300-4400 AA) with ATN1. Interacts with RERE. Interacts (via EVH1 domains) with ENAH By similarity. Interacts (via cytoplasmic domain) with CTNNB1 By similarity. Ref.5 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Nucleus. Cytoplasm › perinuclear region Ref.3. |
| Tissue specificity | Expressed in many epithelial and some endothelial and smooth muscle cells. |
| Domain | A PTB-like motif (DNXYH sequence) is required for the targeting to the leading edge. This motif represents a minimal protein-protein interaction core motif that is not regulated by tyrosine phosphorylation By similarity. |
| Post-translational modification | Undergoes proteolytic cleavage. The extracellular domain is cleaved off and the cytoplasmic domain (about 400 AA) shuttles to the nucleus. Ref.3 |
| Sequence similarities | Contains 33 cadherin domains. Contains 5 EGF-like domains. Contains 1 laminin G-like domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||
| Chain | 22 – 4588 | 4567 | Protocadherin Fat 1 | PRO_0000004017 | |||||||
| Chain | ? – 4588 | Protocadherin Fat 1, nuclear form | PRO_0000408559 | ||||||||
Regions | |||||||||||
| Topological domain | 22 – 4181 | 4160 | Extracellular Potential | ||||||||
| Transmembrane | 4182 – 4202 | 21 | Helical; Potential | ||||||||
| Topological domain | 4203 – 4588 | 386 | Cytoplasmic Potential | ||||||||
| Domain | 35 – 149 | 115 | Cadherin 1 | ||||||||
| Domain | 150 – 257 | 108 | Cadherin 2 | ||||||||
| Domain | 368 – 463 | 96 | Cadherin 3 | ||||||||
| Domain | 464 – 569 | 106 | Cadherin 4 | ||||||||
| Domain | 570 – 673 | 104 | Cadherin 5 | ||||||||
| Domain | 718 – 822 | 105 | Cadherin 6 | ||||||||
| Domain | 823 – 927 | 105 | Cadherin 7 | ||||||||
| Domain | 928 – 1034 | 107 | Cadherin 8 | ||||||||
| Domain | 1035 – 1139 | 105 | Cadherin 9 | ||||||||
| Domain | 1140 – 1245 | 106 | Cadherin 10 | ||||||||
| Domain | 1246 – 1357 | 112 | Cadherin 11 | ||||||||
| Domain | 1359 – 1456 | 98 | Cadherin 12 | ||||||||
| Domain | 1457 – 1562 | 106 | Cadherin 13 | ||||||||
| Domain | 1563 – 1667 | 105 | Cadherin 14 | ||||||||
| Domain | 1668 – 1765 | 98 | Cadherin 15 | ||||||||
| Domain | 1766 – 1879 | 114 | Cadherin 16 | ||||||||
| Domain | 1880 – 1979 | 100 | Cadherin 17 | ||||||||
| Domain | 1980 – 2081 | 102 | Cadherin 18 | ||||||||
| Domain | 2082 – 2182 | 101 | Cadherin 19 | ||||||||
| Domain | 2183 – 2283 | 101 | Cadherin 20 | ||||||||
| Domain | 2284 – 2390 | 107 | Cadherin 21 | ||||||||
| Domain | 2391 – 2492 | 102 | Cadherin 22 | ||||||||
| Domain | 2493 – 2596 | 104 | Cadherin 23 | ||||||||
| Domain | 2597 – 2703 | 107 | Cadherin 24 | ||||||||
| Domain | 2704 – 2809 | 106 | Cadherin 25 | ||||||||
| Domain | 2810 – 2918 | 109 | Cadherin 26 | ||||||||
| Domain | 2919 – 3023 | 105 | Cadherin 27 | ||||||||
| Domain | 3024 – 3125 | 102 | Cadherin 28 | ||||||||
| Domain | 3126 – 3230 | 105 | Cadherin 29 | ||||||||
| Domain | 3231 – 3335 | 105 | Cadherin 30 | ||||||||
| Domain | 3336 – 3440 | 105 | Cadherin 31 | ||||||||
| Domain | 3441 – 3545 | 105 | Cadherin 32 | ||||||||
| Domain | 3546 – 3647 | 102 | Cadherin 33 | ||||||||
| Domain | 3790 – 3827 | 38 | EGF-like 1 | ||||||||
| Domain | 3829 – 4009 | 181 | Laminin G-like | ||||||||
| Domain | 4013 – 4050 | 38 | EGF-like 2 | ||||||||
| Domain | 4052 – 4088 | 37 | EGF-like 3 | ||||||||
| Domain | 4089 – 4125 | 37 | EGF-like 4 | ||||||||
| Domain | 4127 – 4163 | 37 | EGF-like 5; calcium-binding Potential | ||||||||
| Motif | 4204 – 4214 | 11 | Nuclear localization signal Potential | ||||||||
| Motif | 4378 – 4382 | 5 | PTB-like motif By similarity | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 40 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 333 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 660 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 740 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 791 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 998 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1426 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1551 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1748 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1864 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1902 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1940 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1991 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2325 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2464 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3324 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3415 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||||
| Glycosylation | 3422 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||||
| Glycosylation | 3444 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3613 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3640 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 3716 | 1 | N-linked (GlcNAc...) Ref.6 Ref.7 | ||||||||
| Glycosylation | 4152 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 3794 ↔ 3805 | By similarity | |||||||||
| Disulfide bond | 3799 ↔ 3816 | By similarity | |||||||||
| Disulfide bond | 3818 ↔ 3826 | By similarity | |||||||||
| Disulfide bond | 3976 ↔ 4009 | By similarity | |||||||||
| Disulfide bond | 4017 ↔ 4028 | By similarity | |||||||||
| Disulfide bond | 4022 ↔ 4038 | By similarity | |||||||||
| Disulfide bond | 4040 ↔ 4049 | By similarity | |||||||||
| Disulfide bond | 4056 ↔ 4067 | By similarity | |||||||||
| Disulfide bond | 4061 ↔ 4076 | By similarity | |||||||||
| Disulfide bond | 4078 ↔ 4087 | By similarity | |||||||||
| Disulfide bond | 4093 ↔ 4104 | By similarity | |||||||||
| Disulfide bond | 4098 ↔ 4113 | By similarity | |||||||||
| Disulfide bond | 4115 ↔ 4124 | By similarity | |||||||||
| Disulfide bond | 4131 ↔ 4142 | By similarity | |||||||||
| Disulfide bond | 4136 ↔ 4151 | By similarity | |||||||||
| Disulfide bond | 4153 ↔ 4162 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 131 | 1 | A → V. Corresponds to variant rs3733415 [ dbSNP | Ensembl ]. | VAR_055590 | |||||||
| Natural variant | 1330 | 1 | N → S. Corresponds to variant rs874111 [ dbSNP | Ensembl ]. | VAR_055591 | |||||||
| Natural variant | 1564 | 1 | A → T. Corresponds to variant rs2304867 [ dbSNP | Ensembl ]. | VAR_055592 | |||||||
| Natural variant | 1605 | 1 | N → D. Corresponds to variant rs6836935 [ dbSNP | Ensembl ]. | VAR_055593 | |||||||
| Natural variant | 3800 | 1 | P → H. Corresponds to variant rs11731738 [ dbSNP | Ensembl ]. | VAR_055594 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 322 | 1 | G → D in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 404 | 1 | S → R in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 482 | 1 | V → I in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 614 | 1 | F → L in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 862 | 1 | V → L in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 1064 | 1 | R → G in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 1273 | 1 | H → R in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 1351 | 1 | P → Q in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 1526 – 1529 | 4 | HQHT → SPAH in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 1604 | 1 | G → GNIG in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 2006 | 1 | N → S in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 2054 | 1 | T → I in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 2385 | 1 | D → G in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 2618 – 2619 | 2 | VL → S in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 2718 | 1 | I → V in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 3113 | 1 | L → V in CAA60685. Ref.1 | ||||||||
| Sequence conflict | 4059 | 1 | K → N in CAA60685. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule." Dunne J., Hanby A.M., Poulsom R., Jones T.A., Sheer D., Chin W.G., Da S.M., Zhao Q., Beverley P.C.L., Owen M.J. Genomics 30:207-223(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Lymphocyte. |
| [2] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "Processing of the human protocadherin Fat1 and translocation of its cytoplasmic domain to the nucleus." Magg T., Schreiner D., Solis G.P., Bade E.G., Hofer H.W. Exp. Cell Res. 307:100-108(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE. |
| [4] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [5] | "Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells." Hou R., Sibinga N.E. J. Biol. Chem. 284:6955-6965(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ATN1 AND RERE. |
| [6] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-3415; ASN-3422 AND ASN-3716, MASS SPECTROMETRY. Tissue: Liver. |
| [7] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-3716, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [8] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X87241 mRNA. Translation: CAA60685.1. AC107050 Genomic DNA. No translation available. AC110761 Genomic DNA. No translation available. |
| IPI | IPI00940698. |
| RefSeq | NP_005236.2. NM_005245.3. |
| UniGene | Hs.481371. |
3D structure databases | |
| ProteinModelPortal | Q14517. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q14517. 2 interactions. |
| MINT | MINT-2806731. |
| STRING | 9606.ENSP00000406229. |
PTM databases | |
| PhosphoSite | Q14517. |
Polymorphism databases | |
| DMDM | 8928104. |
Proteomic databases | |
| PaxDb | Q14517. |
| PRIDE | Q14517. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000441802; ENSP00000406229; ENSG00000083857. |
| GeneID | 2195. |
| KEGG | hsa:2195. |
| UCSC | uc003izf.3. human. |
Organism-specific databases | |
| CTD | 2195. |
| GeneCards | GC04M187508. |
| HGNC | HGNC:3595. FAT1. |
| HPA | HPA001869. HPA023882. |
| MIM | 600976. gene. |
| neXtProt | NX_Q14517. |
| PharmGKB | PA164719952. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG12793. |
| HOGENOM | HOG000046499. |
| HOVERGEN | HBG005641. |
| InParanoid | Q14517. |
| KO | K16506. |
Gene expression databases | |
| ArrayExpress | Q14517. |
| Bgee | Q14517. |
| CleanEx | HS_FAT1. |
| Genevestigator | Q14517. |
| GermOnline | ENSG00000083857. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.60.120.200. 2 hits. 2.60.40.60. 33 hits. |
| InterPro | IPR002126. Cadherin. IPR015919. Cadherin-like. IPR020894. Cadherin_CS. IPR008985. ConA-like_lec_gl_sf. IPR013320. ConA-like_subgrp. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR001791. Laminin_G. [Graphical view] |
| Pfam | PF00028. Cadherin. 29 hits. PF00008. EGF. 2 hits. PF07645. EGF_CA. 1 hit. PF02210. Laminin_G_2. 1 hit. [Graphical view] |
| PRINTS | PR00205. CADHERIN. |
| SMART | SM00112. CA. 34 hits. SM00181. EGF. 3 hits. SM00179. EGF_CA. 1 hit. SM00282. LamG. 1 hit. [Graphical view] |
| SUPFAM | SSF49313. Cadherin. 33 hits. SSF49899. ConA_like_lec_gl. 1 hit. |
| PROSITE | PS00010. ASX_HYDROXYL. 1 hit. PS00232. CADHERIN_1. 17 hits. PS50268. CADHERIN_2. 33 hits. PS00022. EGF_1. 4 hits. PS01186. EGF_2. 1 hit. PS50026. EGF_3. 5 hits. PS01187. EGF_CA. 1 hit. PS50025. LAM_G_DOMAIN. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | FAT1. human. |
| GenomeRNAi | 2195. |
| NextBio | 8873. |
| SOURCE | Search... |
Entry information
| Entry name | FAT1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q14517 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
